• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[哌拉西林在化脓性脑膜炎患者脑脊液中的穿透情况]

[Penetration of piperacillin into the cerebrospinal fluid of patients with purulent meningitis].

作者信息

Decazes J M, Meulemans A, Bure A, Laisne M J, Modai J

出版信息

Presse Med. 1984 Feb 11;13(5):261-4.

PMID:6229775
Abstract

Ten patients with purulent meningitis received 3 intravenous injections of 4 g piperacillin at intervals of 8 hours, in addition to the usual antimicrobial treatment. Piperacillin was assayed in serum and CSF by high performance liquid chromatography. The mean CSF concentration of the drug was 9.2 micrograms/ml and its mean percentage of penetration was 22,7%. There were no significant differences in CSF concentrations between days 2 to 4 (inflamed meninges) and days 10 to 20 (patient cured). It is concluded that piperacillin shows good CSF penetration and could be useful to treat selected cases of meningitis due to Gram-negative bacilli.

摘要

10例化脓性脑膜炎患者除接受常规抗菌治疗外,还每隔8小时静脉注射3次4克哌拉西林。采用高效液相色谱法测定血清和脑脊液中的哌拉西林。该药物的脑脊液平均浓度为9.2微克/毫升,平均渗透百分比为22.7%。在第2至4天(脑膜发炎)和第10至20天(患者治愈)之间,脑脊液浓度没有显著差异。结论是哌拉西林具有良好的脑脊液渗透性,可用于治疗某些革兰氏阴性杆菌引起的脑膜炎病例。

相似文献

1
[Penetration of piperacillin into the cerebrospinal fluid of patients with purulent meningitis].[哌拉西林在化脓性脑膜炎患者脑脊液中的穿透情况]
Presse Med. 1984 Feb 11;13(5):261-4.
2
Piperacillin in early neonatal infection.哌拉西林用于早期新生儿感染
Arch Dis Child. 1983 Dec;58(12):1006-9. doi: 10.1136/adc.58.12.1006.
3
Penetration of ceftazidime into cerebrospinal fluid of patients with bacterial meningitis.头孢他啶在细菌性脑膜炎患者脑脊液中的渗透情况。
Antimicrob Agents Chemother. 1983 Jul;24(1):126-8. doi: 10.1128/AAC.24.1.126.
4
[Treatment of 18 cases of purulent meningitis with moxalactam. Pharmacokinetic data].[用氧哌嗪青霉素治疗18例化脓性脑膜炎。药代动力学数据]
Presse Med. 1983 Jan 22;12(3):139-42.
5
Clinical significance of cerebrospinal fluid inhibitory titers of antibiotics, based on pharmacokinetic/pharmacodynamic parameters, in the treatment of bacterial meningitis.基于药代动力学/药效学参数的脑脊液抗生素抑制效价在细菌性脑膜炎治疗中的临床意义
J Infect Chemother. 2009 Aug;15(4):233-8. doi: 10.1007/s10156-009-0697-5. Epub 2009 Aug 18.
6
Pharmacokinetics and cerebrospinal fluid penetration of norvancomycin in Chinese adult patients.中国成年患者去甲万古霉素的药代动力学和脑脊液穿透性。
Int J Antimicrob Agents. 2017 May;49(5):603-608. doi: 10.1016/j.ijantimicag.2017.01.014. Epub 2017 Mar 30.
7
Moxalactam penetration into cerebrospinal fluid in patients with bacterial meningitis.细菌脑膜炎患者中莫西拉坦向脑脊液的渗透情况。
Antimicrob Agents Chemother. 1982 Apr;21(4):551-3. doi: 10.1128/AAC.21.4.551.
8
Entry of ciprofloxacin into cerebrospinal fluid during bacterial, viral and tuberculous meningitis.
Neurol Croat. 1991;40(2):111-6.
9
[Transferability of tazobactam/piperacillin (TAZ/PIPC) to cerebrospinal fluid of rabbit with meningitis caused by Staphylococcus aureus].[哌拉西林/他唑巴坦(TAZ/PIPC)在金黄色葡萄球菌所致兔脑膜炎模型中的脑脊液透过率]
Jpn J Antibiot. 1998 Jun;51(6):432-6.
10
Cefoxitin penetration into cerebrospinal fluid in patients with purulent meningitis.头孢西丁在化脓性脑膜炎患者脑脊液中的渗透情况。
Antimicrob Agents Chemother. 1980 Apr;17(4):526-9. doi: 10.1128/AAC.17.4.526.

引用本文的文献

1
Kinetics of piperacillin and tazobactam in ventricular cerebrospinal fluid of hydrocephalic patients.哌拉西林和他唑巴坦在脑积水患者脑室脑脊液中的动力学
Antimicrob Agents Chemother. 1997 May;41(5):987-91. doi: 10.1128/AAC.41.5.987.
2
Different ratios of the piperacillin-tazobactam combination for treatment of experimental meningitis due to Klebsiella pneumoniae producing the TEM-3 extended-spectrum beta-lactamase.不同比例的哌拉西林-他唑巴坦组合用于治疗由产TEM-3超广谱β-内酰胺酶的肺炎克雷伯菌引起的实验性脑膜炎。
Antimicrob Agents Chemother. 1994 Feb;38(2):195-9. doi: 10.1128/AAC.38.2.195.
3
Piperacillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
哌拉西林。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1984 Nov;28(5):375-425. doi: 10.2165/00003495-198428050-00002.